BLZF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.274180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.661400E-01
Normal-vs-Stage2
9.485600E-02
Normal-vs-Stage3
6.573800E-01
Normal-vs-Stage4
1.693230E-01
Stage1-vs-Stage2
8.834800E-01
Stage1-vs-Stage3
2.350400E-01
Stage1-vs-Stage4
3.087200E-01
Stage2-vs-Stage3
1.253040E-01
Stage2-vs-Stage4
4.202400E-01
Stage3-vs-Stage4
1.656830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.412570E-01
Normal-vs-AfricanAmerican
1.638280E-02
Normal-vs-Asian
1.743590E-01
Caucasian-vs-AfricanAmerican
4.195400E-01
Caucasian-vs-Asian
3.861400E-01
AfricanAmerican-vs-Asian
9.090800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.390790E-01
Normal-vs-Female
1.220210E-01
Male-vs-Female
9.963600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.578600E-01
Normal-vs-Age(41-60Yrs)
7.543600E-02
Normal-vs-Age(61-80Yrs)
1.667790E-01
Normal-vs-Age(81-100Yrs)
1.420390E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.382200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.338600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.093400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.486770E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.136000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.079000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.111200E-01
Normal-vs-Daily Drinker
3.821000E-01
Normal-vs-Weekly Drinker
1.700780E-01
Normal-vs-Occasional Drinker
7.803600E-02
Normal-vs-Social Drinker
7.203900E-02
Non Drinker-vs-Daily Drinker
4.631200E-01
Non Drinker-vs-Weekly Drinker
7.734600E-01
Non Drinker-vs-Occasional Drinker
2.510800E-01
Non Drinker-vs-Social Drinker
3.659600E-01
Daily Drinker-vs-Weekly Drinker
4.479200E-01
Daily Drinker-vs-Occasional Drinker
1.403010E-01
Daily Drinker-vs-Social Drinker
2.076800E-01
Weekly Drinker-vs-Occasional Drinker
5.313800E-01
Weekly Drinker-vs-Social Drinker
6.517200E-01
Occasional Drinker-vs-Social Drinker
8.487600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.594180E-01
Normal-vs-Grade 2
2.319600E-02
Normal-vs-Grade 3
2.802100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.539800E-03
Grade 1-vs-Grade 3
4.544700E-03
Grade 1-vs-Grade 4
1.594180E-01
Grade 2-vs-Grade 3
4.276000E-01
Grade 2-vs-Grade 4
2.319600E-02
Grade 3-vs-Grade 4
2.802100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.313800E-01
Normal-vs-NonDiabetic
9.955600E-02
Diabetic-vs-NonDiabetic
6.462500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.476830E-01
Normal-vs-NoPancreatitis
1.504550E-01
Pancreatitis-vs-NoPancreatitis
6.619600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.823020E-01
Normal-vs-N1
9.626300E-02
N0-vs-N1
7.031400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.003600E-04
Normal-vs-TP53-NonMutant
1.687640E-01
TP53-Mutant-vs-TP53-NonMutant
5.015600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
